Clinical Trial Update: Repeated iTBS Cycloserine Motor Plasticity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial on repeated iTBS with serine derivative cycloserine to enhance motor plasticity; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Motor Activity

Drugs mentioned

• cytoserine (cycloserine)
• iTBS

Snippet

Sponsor: University of Calgary | Conditions: Motor Activity | Phase 2 | Status: COMPLETED